Author

Vikas Gaur

DR. B.R.A. Institute Rotary Cancer HospitalORCID 0000-0001-9050-7152Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vikas Gaur1 paper · Rosalind Franklin University of Medicine and Science

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anita ChopraiD· 1 shared Christine WilsoniD· 1 shared Deepam PushpamiD· 1 shared Diwakar SharmaiD· 1 shared Jayanth Kumar PalanichamyiD· 1 shared Priyanka Swaroop· 1 shared Ranjit Kumar SahooiD· 1 shared Sachin KumariD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anita ChopraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 12, 2025

The HOTAIRM1-miR-222 Axis Regulates Venetoclax Resistance and Defines a High-Risk Subset in Pediatric t(8;21) Acute Myeloid Leukemia

Christine Wilson, Priyanka Swaroop, Vikas Gaur…·Surender Kumar Sharawat

The paper identifies HOTAIRM1-miR-222 axis as a regulator of venetoclax resistance and a marker of high-risk t(8;21) AML in pediatric patients.

DOI 10.1101/2025.07.12.663834

humanbulk RNA-seq

𝕏 PostBluesky